Portugal Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Portugal Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: Portugal continues to struggle in the face of continued austerity measures, cuts and the financial obligations of its EU, ECB and IMF economic adjustment package, approved in May 2011. Its prospects deteriorated further in Q213, following the publication of PhRMA’s Special 301 Submission report for 2013. This has called for Portugal to be placed on the Priority Watch List, because of concerns such as that patent protection is not as robust as it should be, that pharmaceutical firms are finding launching products a lengthy process, and that reimbursement procedures are also subject to delays. This will do little … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98786. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/portugal-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions